Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by AntibeTribe on Feb 18, 2021 3:45pm

To the longs

I cannot interpret this news as anything but positive. All we have done is pull the slingshot back a lil further. Cheers gentlemen. This is fantastic.
Comment by MrMugsy on Feb 18, 2021 5:20pm
Agreed.  There's no more guessing as to where the money is going to come from. There's no more racing against the clock. That anxiety has been removed - for company, shareholders and new investors. Bring on the institutional investors !!!!!
Comment by crow27 on Feb 18, 2021 5:35pm
I agree Mugs, This was very high risk investment for everyone without a clear path for phase 3. Sure we got some dilution but what company does not have to bite the bullet at times.  I think most got twisted because we hit the $7's and thought it would keep going. This deal and the Nuance deal has taken so much risk out of the equation. It makes ATB stronger in dealing with other partners ...more  
Comment by MrMugsy on Feb 18, 2021 5:41pm
Yes - and that dilution has an ability to create magnified value in this arena. Imagine a company that just went to market after having its revenue destroyed by COVID (following one of those).  Which one would you rather be a part of ?  Obviously tthis company. We are not going to care about this diluti9on in a lttle while (IMO).
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities